Our UK Diagnostics business, headquartered in Burgess Hill, West Sussex, employs approximately 500 highly skilled individuals. We provide the industry’s broadest range of diagnostics and monitoring products and services, spanning all sectors of the market: from small hand held devices used directly by patients or healthcare professionals, to large diagnostic instruments found in hospital laboratories.
Our handheld devices empower patients to monitor their own chronic conditions easily and accurately. In particular, Roche has developed innovative systems for people with diabetes and those receiving anticoagulation therapy.
In hospitals, our products play two important roles - supporting laboratory services by providing accurate diagnosis of patient samples and enabling the rapid and often life-saving diagnosis of medical conditions in Accident & Emergency, intensive care or in the operating theatre.
Roche pioneered the application of Polymerase Chain Reaction (PCR) technology and our products enable clinicians to monitor the progression of diseases and their patients' response to treatment. We are also one of the world’s leading manufacturers of research reagents and systems for determining the causes of, or people’s predisposition to, disease.
Diagnostics is set to play an increasingly important role in the future of healthcare as genetic knowledge presents new and exciting opportunities. Our desire is to provide clinicians and patients with Actionable Health Information - information that reduces the uncertainty in the medical decision making process, enabling them to choose between available alternatives to prevent or treat disease.